OrganoClick AB (publ) (FRA:0CF)
Germany · Delayed Price · Currency is EUR 0.1230
-0.0080 (-6.11%)
At close: Jan 30, 2026
OrganoClick AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 109.25 | 127.23 | 145.87 | 115.05 | 110.06 | 96.46 | |
Revenue Growth (YoY) | -18.29% | -12.78% | 26.79% | 4.53% | 14.11% | 12.84% |
Cost of Revenue | 87.2 | 95.39 | 110.48 | 91.56 | 91.55 | 76.26 |
Gross Profit | 22.06 | 31.84 | 35.39 | 23.49 | 18.51 | 20.2 |
Selling, General & Admin | 36.68 | 36.88 | 37.23 | 42.86 | 39.94 | 32.73 |
Research & Development | 5.72 | 5.93 | 6.65 | 8.13 | 7.5 | 5.45 |
Other Operating Expenses | -0.57 | -0.43 | 3.26 | -1.18 | -1.03 | -1.1 |
Operating Expenses | 41.83 | 42.38 | 47.14 | 49.81 | 46.41 | 37.08 |
Operating Income | -19.78 | -10.55 | -11.75 | -26.33 | -27.9 | -16.88 |
Interest Expense | -6.35 | -6.17 | -4.96 | -3.23 | -2.65 | -2.53 |
Interest & Investment Income | 0.04 | 0.04 | 0.1 | 0.02 | 0.07 | 0.1 |
Currency Exchange Gain (Loss) | -0.34 | 0.46 | -0.2 | 0.01 | -0.22 | -0.14 |
Other Non Operating Income (Expenses) | 0 | -0 | -0 | - | - | 0 |
EBT Excluding Unusual Items | -26.43 | -16.22 | -16.81 | -29.53 | -30.7 | -19.46 |
Merger & Restructuring Charges | - | - | - | -5.3 | - | - |
Gain (Loss) on Sale of Assets | - | 0.22 | -0.02 | 2.44 | -0.47 | -0.08 |
Asset Writedown | - | - | - | -9.33 | - | - |
Pretax Income | -26.42 | -16 | -14.09 | -41.72 | -31.17 | -19.53 |
Income Tax Expense | 0.19 | 0.18 | 0.07 | -0.1 | -0.14 | -0.01 |
Earnings From Continuing Operations | -26.61 | -16.18 | -14.16 | -41.62 | -31.03 | -19.52 |
Minority Interest in Earnings | 0.26 | -1.79 | -1.62 | -2.78 | -1.65 | -4.13 |
Net Income | -26.35 | -17.97 | -15.77 | -44.4 | -32.69 | -23.65 |
Net Income to Common | -26.35 | -17.97 | -15.77 | -44.4 | -32.69 | -23.65 |
Shares Outstanding (Basic) | 99 | 98 | 98 | 98 | 96 | 92 |
Shares Outstanding (Diluted) | 99 | 98 | 98 | 98 | 96 | 92 |
Shares Change (YoY) | 0.91% | 0.10% | - | 2.17% | 3.66% | 15.70% |
EPS (Basic) | -0.27 | -0.18 | -0.16 | -0.45 | -0.34 | -0.26 |
EPS (Diluted) | -0.27 | -0.18 | -0.16 | -0.45 | -0.34 | -0.26 |
Free Cash Flow | -8.8 | 1.67 | -1.23 | -29.15 | -45.16 | -5.77 |
Free Cash Flow Per Share | -0.09 | 0.02 | -0.01 | -0.30 | -0.47 | -0.06 |
Gross Margin | 20.19% | 25.02% | 24.26% | 20.41% | 16.82% | 20.94% |
Operating Margin | -18.10% | -8.29% | -8.06% | -22.88% | -25.35% | -17.50% |
Profit Margin | -24.12% | -14.12% | -10.81% | -38.59% | -29.70% | -24.51% |
Free Cash Flow Margin | -8.06% | 1.31% | -0.84% | -25.34% | -41.03% | -5.98% |
EBITDA | -13.86 | -5.18 | -6.99 | -19.41 | -21.68 | -12.17 |
EBITDA Margin | -12.69% | -4.07% | -4.79% | -16.87% | -19.70% | -12.62% |
D&A For EBITDA | 5.92 | 5.37 | 4.76 | 6.92 | 6.22 | 4.71 |
EBIT | -19.78 | -10.55 | -11.75 | -26.33 | -27.9 | -16.88 |
EBIT Margin | -18.10% | -8.29% | -8.06% | -22.88% | -25.35% | -17.50% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.